Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07076771

Serum Testosterone Level on Angiographic Complexity of Coronary Lesions in Premature Ischemic Egyptian Males

Impact of Serum Testosterone Level on Angiographic Complexity of Coronary Lesions in Premature Ischemic Egyptian Males

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
Male
Age
45 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the association between serum testosterone levels and the angiographic complexity of coronary artery lesions in male patients under 45 years of age presenting with premature ischemic heart disease.

Detailed description

Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide. While traditionally associated with older populations, there is a growing incidence of premature CAD. Testosterone, the primary male sex hormone, exerts various physiological effects beyond its role in reproductive function. It influences muscle mass, fat distribution, insulin sensitivity, and vascular tone. Low testosterone levels have been associated with adverse metabolic profiles, including increased adiposity, dyslipidemia, and insulin resistance, all of which are established risk factors for atherosclerosis. Furthermore, testosterone deficiency has been linked to endothelial dysfunction, a critical early event in the development of atherosclerotic plaques.

Conditions

Interventions

TypeNameDescription
OTHERCoronary AngiographyAll angiographic procedures will be performed. Coronary artery disease will be defined as \>70% stenosis in at least one major epicardial artery or \>50% the left main coronary artery.
OTHERSyntax ScoreThe angiographic complexity of coronary artery disease (CAD) will be assessed using the SYNTAX score.

Timeline

Start date
2025-01-01
Primary completion
2025-08-01
Completion
2025-08-01
First posted
2025-07-22
Last updated
2025-07-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07076771. Inclusion in this directory is not an endorsement.